Cynthia Seidel-Dugan
3PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Feb 13, 2026
WTX-124, a Conditionally Activated Wild-Type IL2, Maximizes the Therapeutic Index of IL2, Unlike "Non-Alpha" Muteins.Christopher J Nirschl, Kulandayan K Subramanian, Heather R Brodkin
|Apr 19, 2023
mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity.Christopher J Nirschl, Heather R Brodkin, Celesztina Domonkos
|Mar 14, 2022
Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression.Christopher J Nirschl, Heather R Brodkin, Daniel J Hicklin
Pageof 1
Frequent Collaborators
3 joint publications
Nesreen S Ismail
3 joint publications
Jenna M Sullivan
3 joint publications
Andres Salmeron
2 joint publications
Christopher J Nirschl
2 joint publications
Heather R Brodkin
2 joint publications
Celesztina Domonkos
2 joint publications
Connor J Dwyer
2 joint publications
Daniel J Hicklin
2 joint publications
Zoe Steuert
2 joint publications
William M Winston
